The advertisement promotes Repatha® (evolocumab) for very high-risk ASCVD patients, highlighting its efficacy in achieving LDL-C reduction and referencing clinical guidelines.
Creative Information
| CID: | 25b7150c-69e8-41a0-bfeb-6cc1eec136a1 |
| CRID: | 89_232657 |
| Domain: | repatha.com |
| Seat: | DInt |
| Size: | 300x250 |
| Bid: | $1.50 |
| Timestamp: | 11/13/2025, 3:26:28 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 12/10/2025, 6:06:26 PM | 5.53s | |
| adomain_analysis | success | 12/10/2025, 6:13:23 PM | 3.14s | |
| adomain_capture | success | 12/10/2025, 6:13:18 PM | 0.18s | |
| ad_render | success | 12/10/2025, 6:06:20 PM | 26.82s | |
| brand_mapping | success | 12/10/2025, 5:56:48 PM | 0.96s | |
Analysis Results
Ad Format: banner
Brands: Repatha
Sensitive:Pharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 300x250 | ||||||||||||||||||||||
| Data Transferred: | 1544.43 KB | ||||||||||||||||||||||
| Render Time: | 9.01 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 1544.51 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives


